E-Base en es it fr

E-Base Brand names, E-Base Analogs

E-Base Brand Names Mixture

  • No information avaliable

E-Base Chemical_Formula


E-Base RX_link

No information avaliable

E-Base fda sheet

E-Base msds (material safety sheet)

E-Base Synthesis Reference

No information avaliable

E-Base Molecular Weight

167.205 g/mol

E-Base Melting Point

96 oC

E-Base H2O Solubility

2500 mg/L

E-Base State


E-Base LogP


E-Base Dosage Forms

No information avaliable

E-Base Indication

Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.

E-Base Pharmacology

Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.

E-Base Absorption

Rapidly absorbed following oral administration.

E-Base side effects and Toxicity

Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.

E-Base Patient Information

E-Base Organisms Affected

Humans and other mammals